157 related articles for article (PubMed ID: 31737436)
1. A Panel of Circulating MicroRNAs Detects Uveal Melanoma With High Precision.
Stark MS; Gray ES; Isaacs T; Chen FK; Millward M; McEvoy A; Zaenker P; Ziman M; Soyer HP; Glasson WJ; Warrier SK; Stark AL; Rolfe OJ; Palmer JM; Hayward NK
Transl Vis Sci Technol; 2019 Nov; 8(6):12. PubMed ID: 31737436
[TBL] [Abstract][Full Text] [Related]
2. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
3. The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression.
Wróblewska JP; Lach MS; Ustaszewski A; Kulcenty K; Ibbs M; Jagiełło I; Suchorska WM; Marszałek A
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32131485
[TBL] [Abstract][Full Text] [Related]
4. A preliminary study of microRNA expression in different types of primary melanoma.
Gencia I; Baderca F; Avram S; Gogulescu A; Marcu A; Seclaman E; Marian C; Solovan C
Bosn J Basic Med Sci; 2020 May; 20(2):197-208. PubMed ID: 31479413
[TBL] [Abstract][Full Text] [Related]
5. Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma.
Zhou WD; Shao L; Dong L; Zhang RH; Li YF; Li HY; Wu HT; Shi XH; Wei WB
Front Oncol; 2022; 12():854253. PubMed ID: 35433428
[TBL] [Abstract][Full Text] [Related]
6. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
7. Increased Levels of miRNA-146a in Serum and Histologic Samples of Patients with Uveal Melanoma.
Russo A; Caltabiano R; Longo A; Avitabile T; Franco LM; Bonfiglio V; Puzzo L; Reibaldi M
Front Pharmacol; 2016; 7():424. PubMed ID: 27895580
[No Abstract] [Full Text] [Related]
8. Long Noncoding RNA PVT1 Silencing Prevents the Development of Uveal Melanoma by Impairing MicroRNA-17-3p-Dependent MDM2 Upregulation.
Wu S; Chen H; Han N; Zhang C; Yan H
Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4904-4914. PubMed ID: 31770435
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.
Dong F; Lou D
Mol Vis; 2012; 18():537-46. PubMed ID: 22419847
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
Chen X; Wang J; Shen H; Lu J; Li C; Hu DN; Dong XD; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1193-9. PubMed ID: 21051724
[TBL] [Abstract][Full Text] [Related]
11. Translation of a circulating miRNA signature of melanoma into a solid tissue assay to improve diagnostic accuracy and precision.
Laar RV; King S; McCoy R; Saad M; Fereday S; Winship I; Uzzell C; Landgren A
Biomark Med; 2021 Sep; 15(13):1111-1122. PubMed ID: 34184547
[No Abstract] [Full Text] [Related]
12. Expression of natural killer cell regulatory microRNA by uveal melanoma cancer stem cells.
Joshi P; Kooshki M; Aldrich W; Varghai D; Zborowski M; Singh AD; Triozzi PL
Clin Exp Metastasis; 2016 Dec; 33(8):829-838. PubMed ID: 27565163
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease.
Achberger S; Aldrich W; Tubbs R; Crabb JW; Singh AD; Triozzi PL
Mol Immunol; 2014 Apr; 58(2):182-6. PubMed ID: 24370793
[TBL] [Abstract][Full Text] [Related]
14. In-depth characterization of microRNA transcriptome in melanoma.
Kozubek J; Ma Z; Fleming E; Duggan T; Wu R; Shin DG; Dadras SS
PLoS One; 2013; 8(9):e72699. PubMed ID: 24023765
[TBL] [Abstract][Full Text] [Related]
15. microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis.
Babapoor S; Horwich M; Wu R; Levinson S; Gandhi M; Makkar H; Kristjansson A; Chang M; Dadras SS
Mod Pathol; 2016 May; 29(5):461-75. PubMed ID: 26916074
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1.
Li Y; Huang Q; Shi X; Jin X; Shen L; Xu X; Wei W
Chin Med J (Engl); 2014; 127(8):1410-6. PubMed ID: 24762580
[TBL] [Abstract][Full Text] [Related]
17. miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: Pathological and diagnostic implications.
Ragusa M; Barbagallo C; Statello L; Caltabiano R; Russo A; Puzzo L; Avitabile T; Longo A; Toro MD; Barbagallo D; Valadi H; Di Pietro C; Purrello M; Reibaldi M
Cancer Biol Ther; 2015; 16(9):1387-96. PubMed ID: 25951497
[TBL] [Abstract][Full Text] [Related]
18. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
[TBL] [Abstract][Full Text] [Related]
19. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
[TBL] [Abstract][Full Text] [Related]
20. Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma.
Ruggiero CF; Fattore L; Terrenato I; Sperati F; Salvati V; Madonna G; Capone M; Valenti F; Di Martino S; Mandoj C; Liguoro D; Castaldo V; Cafaro G; Simeone E; Vanella V; Russillo M; Conti L; Cuda G; Giannarelli D; Ascierto PA; Mancini R; Ciliberto G
Theranostics; 2022; 12(17):7420-7430. PubMed ID: 36438490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
